GCP
CBPO

GSA Capital Partners’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

GSA Capital Partners’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,511
Closed -$359K – 1481
2020
Q2 		$359K Buy
+3,511
New +$376K 0.2% 131
2020
Q1 		– Sell
-2,500
Closed -$291K – 1793
2019
Q4 		$291K Hold
2,500
– – 0.03% 1051
2019
Q3 		$286K Buy
+2,500
New +$249K 0.04% 935
2018
Q3 		– Sell
-15,900
Closed -$1.58M – 2085
2018
Q2 		$1.58M Sell
15,900
-13,010
-45% -$1.12M 0.08% 418
2018
Q1 		$2.34M Buy
28,910
+710
+3% +$57.4K 0.12% 206
2017
Q4 		$2.22M Buy
28,200
+15,285
+118% +$1.27M 0.14% 193
2017
Q3 		$1.19M Sell
12,915
-1,600
-11% -$154K 0.08% 405
2017
Q2 		$1.64M Buy
14,515
+12,300
+555% +$1.37M 0.11% 239
2017
Q1 		$222K Sell
2,215
-21,622
-91% -$2.31M 0.01% 1521
2016
Q4 		$2.56M Sell
23,837
-5,084
-18% -$594K 0.15% 132
2016
Q3 		$3.6M Sell
28,921
-12,894
-31% -$1.52M 0.19% 66
2016
Q2 		$4.45M Buy
41,815
+1,320
+3% +$153K 0.25% 25
2016
Q1 		$4.64M Sell
40,495
-2,799
-6% -$328K 0.3% 12
2015
Q4 		$6.17M Sell
43,294
-7,621
-15% -$880K 0.3% 15
2015
Q3 		$4.57M Buy
50,915
+12,000
+31% +$1.27M 0.22% 51
2015
Q2 		$4.48M Buy
38,915
+2,200
+6% +$231K 0.17% 68
2015
Q1 		$3.51M Buy
36,715
+14,200
+63% +$1.06M 0.14% 113
2014
Q4 		$1.51M Buy
22,515
+400
+2% +$24.8K 0.11% 241
2014
Q3 		$1.19M Buy
22,115
+7,700
+53% +$379K 0.06% 389
2014
Q2 		$641K Buy
14,415
+8,522
+145% +$348K 0.03% 973
2014
Q1 		$204K Sell
5,893
-11,400
-66% -$363K 0.01% 1380
2013
Q4 		$499K Sell
17,293
-10,600
-38% -$307K 0.04% 848
2013
Q3 		$815K Buy
27,893
+2,800
+11% +$69.8K 0.06% 467
2013
Q2 		$582K Buy
+25,093
New +$633K 0.07% 462

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

GSA Capital Partners's CBPO Position: Q3 2020 in Review

GSA Capital Partners sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2020, closing a stake of 3,511 shares — an estimated $359K sold.

GSA Capital Partners first reported a position in CBPO in Q2 2013 and held it in 24 quarters. The position peaked at $6.17M in Q4 2015. 87 funds tracked by Wall St. Rank hold CBPO as of Q3 2020.

  • GSA Capital Partners reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2020 after selling out during the quarter.
  • GSA Capital Partners sold 3,511 China Biologic Products Holdings, Inc. shares in Q3 2020, an estimated $359K.
  • GSA Capital Partners first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 24 quarters.
  • GSA Capital Partners's China Biologic Products Holdings, Inc. position peaked at $6.17M in Q4 2015.
  • 87 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2020.

Based on GSA Capital Partners's 13F filing for Q3 2020, filed 6 Nov 2020.